1.930USD+1.930After-hours 07/30, 20:00 (ET)
16.12MMarket Cap
179.91P/E TTM
Jin Medical International Ltd
ZJYL Balance Sheet
You can check out the annual or quarterly balance sheets of Jin Medical International Ltd here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing ZJYL stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Jin Medical International Ltd Have?
In its most recent quarterly, Jin Medical International Ltd had 11.13M in cash and cash equivalents.
What Are Jin Medical International Ltd's Total Assets?
As of the latest reported quarter, Jin Medical International Ltd's total assets were 53.37M, consisting of 44.14M in current assets and 9.23M in non-current assets.
How Much Shareholders' Equity Does Jin Medical International Ltd Have?
Jin Medical International Ltd reported 29.57M in total shareholders' equity as of the latest reported quarter.